Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Carisma Therapeutics, Inc. (NASDAQ:CARM – Get Free Report) has earned an average recommendation of “Hold” from the seven ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from Buy to ...

In a report released today, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

On Tuesday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.27 which represents a decrease of $-0.01 or -3.57% from the prior close of $0.28. The stock opened at $0.28 and ...

Frontline plc (NYSE:FRO) is a company engaged in seaborne transportation of crude oil and refined products. The company owns ...

BTIG raised the firm’s price target on Chefs’ Warehouse (CHEF) to $58 from $50 and keeps a Buy rating on the shares. The firm believes ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) has earned a consensus recommendation of “Hold” from the twenty ...

After fast-food chains tried to win over inflation-weary customers with discounts last year, McDonald's Corp. kicked off 2025 with yet another deal, launching its new "McValue" menu intended to offer ...

BTIG Research has recently reduced Fiverr International Ltd (FVRR) stock to Neutral rating, as announced on November 4, 2024, according to Finviz. Earlier, on July 2, 2024, UBS had reduced the stock ...

Short seller Hindenburg Research accused Carvana of accounting manipulation and unstable loans. The company denies the ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...